title: Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.
authors.affiliation: Unità di Angiologia, Ospedale San Giacomo, Castelfranco Veneto (TV), Italy. adriana.visona@ulssasolo.ven.it
authors.forename: Adriana
authors.initials: A
authors.lastname: Visonà
authors.forename: Diego
authors.initials: D
authors.lastname: Tonello
authors.forename: Beniamino
authors.initials: B
authors.lastname: Zalunardo
authors.forename: Sandro
authors.initials: S
authors.lastname: Irsara
authors.forename: Guido
authors.initials: G
authors.lastname: Liessi
authors.forename: Lucia
authors.initials: L
authors.lastname: Marigo
authors.forename: Laura
authors.initials: L
authors.lastname: Zotta
mesh_terms: D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000534:rehabilitation; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D023903:Coronary Restenosis / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use; D004338:Drug Combinations; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy
chemical_list: D000911:Antibodies, Monoclonal; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; C446540:thienopyridine; D004176:Dipyridamole; D001241:Aspirin; D000077284:Abciximab